The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome
- 1 June 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 22 (3), 193-201
- https://doi.org/10.1097/gco.0b013e3283384911
Abstract
Not availableSimone L. Broer, BenWillem Mol, Madeleine Dólleman, Bart C. Fauser and Frank J.M. BroekmanKeywords
This publication has 84 references indexed in Scilit:
- Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patientsJournal of Assisted Reproduction and Genetics, 2009
- Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-Müllerian hormone versus small antral follicle count (2–6 mm)Journal of Assisted Reproduction and Genetics, 2009
- The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle countFertility and Sterility, 2009
- Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserveJournal of Assisted Reproduction and Genetics, 2008
- Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause TransitionJournal of Clinical Endocrinology & Metabolism, 2008
- How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysisFertility and Sterility, 2008
- Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulationHuman Reproduction Update, 2007
- Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetateFertility and Sterility, 2006
- Müllerian Inhibiting Substance Gene Expression in the Cycling Rat Ovary Correlates with Recruited or Graafian Follicle Selection1Biology of Reproduction, 1994
- Delaying childbearing: effect of age on fecundity and outcome of pregnancy.BMJ, 1991